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Abstract
The pathogenesis of polycystic ovary syndrome (PCOS) is poorly understood. PCOS-like phenotypes are produced by
prenatal androgenization (PA) of female rhesus monkeys. We hypothesize that perturbation of the epigenome, through
altered DNA methylation, is one of the mechanisms whereby PA reprograms monkeys to develop PCOS. Infant and adult
visceral adipose tissues (VAT) harvested from 15 PA and 10 control monkeys were studied. Bisulfite treated samples were
subjected to genome-wide CpG methylation analysis, designed to simultaneously measure methylation levels at 27,578 CpG
sites. Analysis was carried out using Bayesian Classification with Singular Value Decomposition (BCSVD), testing all probes
simultaneously in a single test. Stringent criteria were then applied to filter out invalid probes due to sequence
dissimilarities between human probes and monkey DNA, and then mapped to the rhesus genome. This yielded differentially
methylated loci between PA and control monkeys, 163 in infant VAT, and 325 in adult VAT (BCSVD P,0.05). Among these
two sets of genes, we identified several significant pathways, including the antiproliferative role of TOB in T cell signaling
and transforming growth factor-b (TGF-b) signaling. Our results suggest PA may modify DNA methylation patterns in both
infant and adult VAT. This pilot study suggests that excess fetal androgen exposure in female nonhuman primates may
predispose to PCOS via alteration of the epigenome, providing a novel avenue to understand PCOS in humans.
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Introduction
Polycystic ovary syndrome (PCOS) is a common endocrine
disorder, occurring in 7-10% of reproductive aged women [1]. Its
heritability has been estimated as high as 0.79 [2]; however, few
susceptibility genes have been identified [3]. The pathogenesis of
PCOS may be explained by an integrated genetic and epigenetic
model [4], with environmental factors contributing to the
development of PCOS by modifying the effects of susceptibility
genes [5].
PCOS-like phenotypes are produced by prenatal androgeniza-
tion (PA) of female mammals including rhesus monkeys, sheep,
rats and mice, suggesting that the intrauterine environment may
play a role in the etiology of PCOS [6]. Fetuses exposed to
elevated androgens in utero later develop PCOS-like phenotypes as
adults, including hyperandrogenism, oligomenorrhea, polyfollicu-
lar ovaries, increased adiposity, insulin resistance and impaired
insulin secretion [6,7]. This phenomenon has been formulated as
the fetal origins of PCOS hypothesis [7].
The underlying mechanism of fetal origins of PCOS, however,
has not been elucidated. Environmental insults during gestation,
often related to sex steroids or endocrine disruptors, may
predispose to adult disease via epigenetic alterations [8,9].
Estrogenic exposure, for example, has been shown to reprogram
differentiation of target cells via DNA methylation changes during
development [10]. Given the crucial effects of epigenetic
mechanisms in fetal origins of other metabolic diseases [11], we
and others [12] hypothesize that perturbation of the epigenome,
through altered DNA methylation during gestation, is a mecha-
nism whereby PA reprograms monkeys to develop PCOS, with
transient gestational hyperglycemia accompanying fetal androgen
excess in PA monkeys [5] possibly contributing to this process.
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Epigenetic differences have been demonstrated in PCOS initially
in the form of X-chromosome inactivation [13,14,15] and
genomic instability [16,17]. Demethylation of the luteinizing
hormone receptor (LHR) gene also has been detected in a
dehydroepiandrosterone (DHEA)-induced mouse model of PCOS
[18]. Importantly, our previous finding that total methylation of
peripheral blood leukocyte DNA is unaltered in PCOS patients
versus matched controls [19] raises the need for site-specific
epigenetic studies in physiologically-relevant target tissues. In the
current pilot study, we performed a genome-wide site-specific
methylation array of visceral adipose tissue (VAT) from PA female
rhesus monkeys to test whether the epigenome of this metabol-
ically important fat depot was altered by intrauterine androgen
exposure. VAT was first studied due to its close association with
metabolic disease [20] and the observation that PA, but not
control, female monkeys develop increased VAT that is positively
correlated with basal serum insulin levels [21,22].
Results
The flowchart of the epigenetic experimental design is displayed
in Figure 1. Relevant phenotypic characteristics of infant and
adult female monkeys whose dams were injected with testosterone
propionate are presented in Tables 1 and 2.
Methylation profiling of infant and adult PA female and
control rhesus monkeys
All samples passed the quality check using background-corrected
b values (methylation percentages) and built-in controls. Among a
total of 27,578 CpG sites, initial quality control generated b values
at 17,111 CpG sites for the 12 infant VAT samples, and at 20,532
CpG sites for the 13 adult VAT samples. This quality control pass
rate (62–74%) in monkey tissues was predictably slightly lower than
that observed in human tissues (,80%) [23].
No outlier was identified using principal component analysis.
The top 5 principal components were selected for further analysis
to determine whether potential variance was associated with
confounding factors, such as DNA concentration, DNA quality
(ODs 260/280), batch/plate effects. No confounding factors were
identified (Table S1). All 25 samples were therefore retained for
further analysis.
Bayesian classification with singular value decomposition
(BCSVD) identified 423 sites from infant PA monkeys versus
controls and 937 sites from adult PA monkeys versus controls as
differentially methylated (P,0.05). After confirming these sites in
the rhesus genome, we identified the valid genes (based on sequence
comparison of human probes to the monkey genome) with altered
methylation levels, resulting in 163 genes from infant data, and 325
from adult data (median methylation levels are given in Table S2
for infant data and Table S3 for adult data). The remaining genes
were excluded from our analysis due to sequence divergence
between species. Our result provides a profile of differential
methylation in both infant and adult PA female monkeys.
Hierarchical clustering analyses on the significantly differentially
methylated probes are displayed in Figure 2 for both adult and
infant data. Within each age group, the controls and PA samples
clustered together. We then compared the two differentially
methylated gene sets from infant and adult, and found only two
genes with similarly altered methylation in both groups (FBXO28
and ZNF512, see Table S4 for full names of genes). The same
probe of FBXO28 was hypermethylated in both infant and adult
PA female monkeys, and two different probes of ZNF512 were
hypomethylated in both androgenized groups.
Pathway analysis and potential biological roles
We investigated potential functional pathways and connections
between genes with significant differential methylation using the
Core analysis algorithm in Ingenuity Pathways Analysis (IPA). The
163 infant genes and 325 adult genes were entered into IPA
respectively. The most significant pathways in infant and adult data,
respectively, were the anti-proliferative role of TOB (protein
encoded by the gene TOB, transducer of v-erb-b2 erythroblastic
leukemia viral oncogene homolog 2 [ERBB2]) in T cell signaling
(P=0.0014), and transforming growth factor-beta (TGF-b) signal-
ing (P=0.00038) (Table 3). The entire pathway diagrams are
shown in Figure S1 (with key to symbols in Figure S3), indicating
significantly differentially methylated genes in PA monkeys within
each pathway. Of note, the anti-proliferative role of TOB pathway
contains SMAD4, a participant in TGF-b signaling.
The HumanMethylation27 was designed with a focus on cancer,
including CpG sites for more than 200 cancer-related and imprinted
genes. Thus, cancer-related pathways are expected to be over-
represented on the array. In order to determine whether the top
pathways identified by IPA were biased by the structure of the array,
we conducted pathway analysis by PANTHER, using as the
reference gene set the entire list of genes (14,475 genes) on the array,
rather than all RefSeq genes. The most significant pathway identified
in infant data was ‘‘salvage pyrimidine ribonucleotides’’ (P=0.014),
and the top significant pathway in adult data was again ‘‘TGF-b
signaling’’ (P=0.0061) (Table S5). These pathways were not among
the most over-represented cancer related pathways on the array (data
not shown), suggesting that the pathways over-represented in infant
and adult data were not biased by the cancer focus of the array.
We also utilized network analysis in IPA to investigate broader
interactions involved in our datasets. The network analysis related
all mapped molecules to a higher order interaction over
represented by our gene lists. The top network in infant data
(Figure S2A, Table S6) contained 23 input focus molecules,
centered around Akt, ERK1/2, hCG, LH, FSH, Creb and
P38MAPK. The top network in adult data (Figure S2B, Table
S6) contained 23 input focus molecules, centered around Akt,
ERK1/2, NFe ˆB, TGFBR1, AR, hCG, CCND1, Creb and
ERBB2. These networks identified putative central molecules as
major functional targets of differential gene methylation in PA
female monkeys, from fetal androgen excess and/or gestational
hyperglycemia. Many molecules implicated in these networks are
involved in regulating adipogenesis and, in agreement with the
above pathway analyses, several factors mediating TGF-b
signaling were implicated in both infant (ERK1/2, Jnk, SMAD4)
and adult (BMP2, ERK1/2, SMAD 2/3, TGFBR1) PA female
monkeys.
Statistical validation and power analysis
To internally validate our findings, we performed leave-one-out
cross-validation (LOOCV) analysis based on the model using the
163 differentially methylated genes determined from the infant
data. Models based on the 163 genes were able to predict the
status of each infant sample with 100% sensitivity and 100%
specificity. LOOCV analysis of the 325 differentially methylated
genes from the adult data performed similarly in the ability to
predict the PA versus control status of each adult sample,
consistent with the results of cluster analysis (Figure 2). These
statistical evaluations affirm the validity of the top differentially
methylated genes we have identified.
In addition, we estimated study power of each model (infant and
adult) using the generalized likelihood ratio (GLR) method. For
the infant model, –lnl was 8.97, and power =1 – Pr(reject H0)= 1
– Pr(x
2(1)$ –2lnl) =1 – Pr(x
2(1)$ 17.95) < 1. Similarly for the
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– Pr(x
2(1)$ 16.49) < 1. This ensures that analyses within both
infants and adults were powered adequately.
Association between methylation levels and androgen
levels in PA female monkeys
We performed regression analyses to determine whether
differentially methylated genes identified above in infant and
adult samples were associated with their circulating androgen
levels (Table 4). Methylation levels of GLO1 and DDB1 were
associated with androgens (testosterone and androstenedione,
respectively) in infant PA monkeys. Serum testosterone levels in
adult PA monkeys were associated with methylation levels of seven
genes: SUV39H2, OACT2, SEPT9, KCNQ5, RAB6A, PRKD1, and
OBFC2B. No associations with androgens were found in controls.
Discussion
This pilot study suggests that alteration of the epigenome is a
mechanism whereby gestational androgen excess, or its conse-
quences, may reprogram fetal female monkeys to develop PCOS-
like traits in adulthood. Significant differentially methylated genes
identified from infant and adult data are involved in TGF-b
signaling, a pathway currently implicated in the pathogenesis of
PCOS in women by genetic epidemiologic evidence [24,25,26,27],
supporting the potential contributory role of epigenomic pertur-
bation in the etiology of PCOS.
One strength of our study is the selection of VAT, an adipose
depot closely linked to metabolic disease [20], which was harvested
from PA and control female monkeys to determine whether the
epigenome of a specific adipose tissue is modified by in utero
androgen exposure and its consequences. This is important
because DNA methylation likely occurs at tissue-specific differen-
tially methylated regions [28], as evidenced by the tissue-specific
differences in methylation levels observed in 12 distinct human
tissues [29]. Another strength of this study is the assessment of
DNA methylation patterns in both infant and adult VAT. Infant
tissues were selected because epigenetic alteration in PA infants
would most closely reflect changes from androgen excess in utero;
adult tissues also were chosen because epigenetic alteration in PA
adults would most likely represent postnatal modifications from
aging, environmental factors and/or metabolic or reproductive
consequences of earlier fetal epigenetic events [30]. In support of
this, our data show essentially no overlap between differentially
methylated genes in infant and adult PA female monkeys,
consistent with monozygotic twins being epigenetically indistin-
guishable during youth, but showing different patterns of genomic
methylated DNA and histone acetylation at older ages [31].
Therefore, an important conclusion of this study is that
methylation is plastic; in the adult monkeys, whether epigenetic
alteration is a cause or consequence of PCOS-like features cannot
be ascertained.
IPA (http://www.geneontology.org) and Panther [32] use
different database libraries for pathway enrichment analysis, which
mayexplaintheapparentlydifferentfindingswhenanalyzinginfant,
but not adult, data. Nevertheless, both programs identified TGF-b
signaling as the same top significant pathway in PA adults. In
infants, the top pathway identified by IPA was anti-proliferative role
of TOB, via SMAD4, the co-SMAD that plays a role in transducing
the signal of most members of the TGF-b superfamily (Figure
S1A). The top IPA-generated network for infant PA monkeys also
implicated SMAD4fromaltered DNAmethylationpatterns(Figure
S2A). Thus, altered methylation in VAT of infants and adults alike
appears to disturb signaling by TGF-b superfamily members in PA
Figure 1. Flow chart of the experimental design and overview of the results.
doi:10.1371/journal.pone.0027286.g001
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TGF-b signaling as a putative genetically-based mechanism for
developing PCOS [24,25,26,27], our findings of altered methyla-
tion of TGFB3, TGFBR1, KRAS, BMP2, TFE3, Runx3 and Hoxc8,
complement previous studies implicating TGF-b superfamily
members or their regulators in the pathophysiology of PCOS,
including anti-Mu ¨llerian hormone (AMH), inhibin B, growth
differentiation factor 9, activin A, follistatin, and fibrillin-3
[24,25,26,27,33,34,35]. Because fibrillins interact with latent
TGF-b binding protein, and both fibrillins and follistatin share
TGF-b binding domains, both regulate extracellular TGF-b
bioactivity [36,37].
Several of the genes whose differential methylation was
associated with androgen levels are involved in cell membrane
function and/or structure (OACT2, acylation of membrane
lysophospholipids; SEPT9, cell division/cell membrane cleavage;
RAB6A, intracellular membrane trafficking [38,39,40]). We
hypothesize that these membrane-related functions may be
important to TGF-b signaling. In support of this, SEPT9 binds
to hypoxia-inducible factor-1a (HIF-1a), which increases tran-
scription of TGF-b [41,42]. Additionally, SUV39H2 binds to and
potentiates the effects of SMAD5, which participates in the
signaling of the bone morphogenetic proteins, which are members
of the TGF-b superfamily [43].
In addition, our pilot study provided additional hypothesis-
generating results, based on network analysis identifying Akt,
ERK1/2, hCG, and Creb (Figure S2) as factors central to infants
and adults. Akt and ERK1/2 participate in insulin [44] and
MAPK signaling pathways (KEGG Pathway Database, http://
www.genome.jp/kegg/); genetic variants of AKT2 have been
associated with PCOS in humans [45], while altered expression of
MAPK signaling pathway components has been demonstrated in
PCOS cumulus cells [46]. It remains to be examined whether
epigenetically-mediated altered interactions between these factors
and hCG/LH in adipose tissue are the basis by which adiposity in
PCOS, as a determinant of abnormal gonadotropin secretion,
alters ovarian function [47].
Some, but not all, recent studies argue against prenatal
androgenization as a possible developmental programming model
for human PCOS. Women from male/female twin pairs were not
found to have an increased prevalence of PCOS versus women
from same sex twin pairs; however, the overall prevalence of
PCOS (3-4%) in that study was lower than reported in most other
populations, possibly limiting the power of the study to detect an
Table 1. Serum androgen levels of PA infant and control
female monkeys.
Monkeys Testosterone (ng/ml) Androstenedione (ng/ml)
Control infants
#1 0.07 0.81
#2 0.08 0.92
#3 0.07 1.07
#4 0.05 0.68
#5N A N A
PA infants
#1 0.17 2.15
#2 0.10 1.06
#3 0.08 0.69
#4 0.08 2.40
#5 1.33 4.26
#6 0.09 0.54
#7N A N A
NA = sample not available.
doi:10.1371/journal.pone.0027286.t001
Table 2. PCOS phenotype for PA adult monkeys.
Monkeys Menstrual cycles (mean duration in days) Ovarian morphology Testosterone (ng/ml)
Adult controls
#1 Normal (26) NA 0.12
#2 Normal (28) NA 0.20
#3 Normal (NA) NA 0.21
#4 Normal (27) NA 0.27
#5 Normal (26) NA NA
PA adults
#1 Normal (31) PCO NA
#2 Intermittent/anovulatory (43) PCO 0.20
#3 Intermittent/anovulatory (93) Normal 0.32
#4 Intermittent/anovulatory (70) PCO 0.48
#5 Intermittent/anovulatory (48) Normal 0.40
#6 Intermittent/anovulatory (52) PCO 0.51
#7 Intermittent/anovulatory (120) PCO 0.29
#8 Intermittent/anovulatory (35) PCO 0.37
PA female rhesus monkeys exhibit a variety of phenotypes similar to those found in PCOS women. PA monkey phenotypes were refined from those previously
described [61,62]; intermittent/anovulatory cycles were defined as cycle lengths longer than 34 days because 92% of normal female rhesus monkeys have menstrual
cycles between 24–34 days [63]; hyperandrogenism was defined as testosterone $0.32 ng/ml, which represents the mean plus one standard deviation in circulating
basal testosterone levels of control monkeys [62]. PCO: polycystic ovary morphology, determined from photos taken via laparoscope during transabdominal
illumination; PCO was defined as the presence of 10 or more ,1–3 mm follicles per greatest ovarian diameter [64]. NA: not available or not assessed.
doi:10.1371/journal.pone.0027286.t002
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were not found to be elevated in adolescent girls later diagnosed
with PCOS [49], nor in one study were they elevated in the infant
offspring of women with PCOS [50]. In contrast, another study
noted elevated testosterone levels in umbilical venous blood of
females born to PCOS women [51]. Moreover, a study of human
fetal blood obtained via cordocentesis found that ,40% of female
fetuses at mid-gestation had testosterone levels in the male range
[52]. Further studies are needed to quantify serum androgen levels
in the mid-gestational human female fetus, which may itself be the
source of androgen excess in utero during a critical time of target
tissue differentiation [7,53].
Although experimentally induced fetal androgen excess is an
artificial system, the fact remains that PA monkeys (as well as
Figure 2. Unsupervised hierarchical clustering. Methylation percentages (b values) at all the significant loci from infant and adult PA monkeys
and control monkeys (panel A: 163 loci for infant data; panel B: 325 loci for adult data). Top horizontal bars indicate sample clusters. Scale displays
methylation percentage (yellow indicates 1; blue indicates 0).
doi:10.1371/journal.pone.0027286.g002
Table 3. Significant canonical pathways associated with differentially methylated genes in infants and adults.
Top Canonical Pathways P-value Ratio Genes
Infant
Anti-proliferative Role of TOB in T Cell Signaling 0.0014 3/26 (0.12) CDKN1B, PABPC1, SMAD4
VDR/RXR Activation 0.028 3/78 (0.038) CAMP, CYP27B1, CDKN1B
Methionine Metabolism 0.029 2/31 (0.065) CBS, MAT2A
Complement System 0.034 2/35 (0.057) CD55, MASP
Nucleotide Excision Repair Pathway 0.036 2/35 (0.057) ERCC8, POLR2D
Adult
TGF-b signaling 0.00038 7/83 (0.084) BMP2, HOXC9, KRAS, RUNX3, TFE3, TGFB3, TGFBR1
Axonal Guidance Signaling 0.00072 16/399 (0.04) ADAM10, ARPC3, BMP2, EFNB1, EPHA5, ERBB2, ITGA2, KRAS,
MYL3, MYL12B, PAK3, PRKAG1, PRKAG2, PRKD1, UNC5B, WNT4
Tight Junction Signaling 0.0019 9/164 (0.055) CPSF3,CSTF3, MAGI2, MYL3, PRKAG1, PRKAG2, SYMPK,TGFB3,
TGFBR1
Polyamine Regulation in Colon Cancer 0.0020 3/17 (0.18) KRAS, MXD1, TCF4
Wnt/B-catenin signaling 0.0024 9/168 (0.054) CCND1, RARB, SFRP1, SFRP5, SOX2, TCF4, TGFB3, TGFBR1, WNT4
doi:10.1371/journal.pone.0027286.t003
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can naturally develop PCOS-like traits without apparent inter-
vention [54]. The PA rhesus model enables us to study
intrauterine androgen influences on fetus and infant, which is
difficult to study in humans. Studying PA rhesus monkeys will be
highly informative to understand underlying epigenetic mecha-
nisms of steroid, and possibly hyperglycemic [5], action, including
molecular factors and/or pathways altered by prenatal androgen
and glucose excess, and to posit pathophysiological processes that
may influence the phenotypic expression of PCOS.
Our genome-wide methylation analysis may have missed some
key factors or networks since it did not interrogate every gene of
the monkey genome (27,578 CpG sites targeted; 14,475 genes
studied) and 20–30% of all probes did not pass the initial quality
control. Nevertheless, this high throughput methylation assay
profiled a large number of genes, most of which would not be
considered in a classical candidate approach. Also, not all CpG
sites need to be assessed because of correlation of methylation
status between sites [55].
In conclusion, this study identified the first specific alterations in
the epigenome of PA infant and adult rhesus monkeys, suggesting
that fetal androgen excess and its consequences have epigenetic
implications for developmental programming of PCOS. While
exhibiting virtually no overlap in terms of specific genes
differentially methylated, the infant and adult methylation
alterations pointed to common pathways of pathogenesis.
Epigenetic alterations in PA monkeys may provide a novel avenue
to understand the developmental origins and pathophysiology of
PCOS in humans.
Materials and Methods
Ethics statement
No work with live animals was conducted in this study. Monkey
tissues harvested at the Wisconsin National Primate Research
Center (WNPRC) were sent to Cedars-Sinai Medical Center for
DNA extraction and epigenetic analysis. Some of the adult female
rhesus monkey tissues were obtained through the WNPRC’s
Nonhuman Biological Material Distribution program. The
WNPRC principal investigator of the studies that originally
obtained the monkey tissues (D.H. Abbott) gave permission for
fellow authors to use harvested samples for this study. The care
and housing of, and harvesting of tissues from, female rhesus
monkeys at both the California National Primate Research Center
(CNPRC) and the WNPRC (infants [56] and adults [57],
respectively) were fully compliant with the recommendations of
the Guide for the Care and Use of Laboratory Animals and the
Animal Welfare Act. All protocols were approved before
implementation by the Institutional Animal Care and Use
Committees at the University of California, Davis and the
Graduate School, University of Wisconsin, Madison.
Samples
The study sample consisted of VAT from 25 female rhesus
monkeys at infant or adult stages. The infant (8–9 weeks of age)
samples comprised VAT from 5 controls and 7 PA monkeys. The
adult (age .17 years) samples consisted of VAT from 5 controls
and 8 PA monkeys with phenotypic derangements resembling
PCOS. Adult controls were selected to match the age, body
weight, and BMI range of the PA females. A detailed description
of study design and methodology has been reported previously
[6,56,57]. Briefly, early gestation-exposed PA female monkeys
were produced by daily subcutaneous injections of their dams with
10–15 mg testosterone propionate for 15–40 consecutive days
beginning on gestational days 40–44 (total gestation, 165610
days). VAT was collected after infant and adult monkeys were
sacrificed. Monkeys were put through timed injection with
ketamine and barbiturate prior to necropsy. During the necropsy
protocol, VAT was obtained from omental depots adjacent to the
gastrointestional tract. VAT was placed into sterile cryovials,
which were immediately placed into liquid nitrogen and
transported to a 280uC freezer soon afterwards.
Three of the 15 infant samples previously described [56] were
excluded from this study. One control infant was omitted as an
outlier due to elevated maternal/fetal basal serum glucose levels in
the third trimester, elevated birth weight, and elevated basal serum
glucose levels at 2 months postnatal age [5]. Two PA infants were
omitted because their mothers had impaired glucose intolerance
during pregnancy, which may alter fetal epigenetic patterns [58].
Regarding adult monkeys, of the 34 adults previously described
[57] we studied a subset of 13 early-gestation PA monkeys that had
undergone necropsy and tissue collection. Some adult PA females
died of natural causes and were found dead in their cages. Necrosis
was too extensive in those cases for useful organ/tissue harvest.
Normal female monkeys were subset driven by need of other
investigators or colony management for necropsy at the WNPRC
(but without treatment prior to euthanasia).
Genome-wide DNA methylation analysis
Genomic DNA was extracted from all 25 VAT samples using
the ALLPrep kit (Qiagen, Valencia, CA), followed by bisulfite
conversion, during which unmethylated cytosine is converted to
uracil, and methylated cytosine is not converted. After whole
genome amplification, samples were subjected to genome-wide
DNA methylation analysis using the Infinium HumanMethyla-
tion27 BeadChip (Illumina, San Diego, CA), which employs two
different bead types to detect CpG methylation. The U beads bind
to unmethylated CpG sites, and the M beads bind to the
methylated sites. The match between bead type and the CpG site
enables single base extension, incorporating a florescence-labeled
ddNTP for detection. Image processing and intensity data
extraction were performed according to Illumina’s instructions.
Methylation status of each interrogated locus is measured as the b
value, representing the ratio of fluorescent signals from the
methylated probes to total locus intensity (M/(M+U)), ranging
Table 4. Significant association between DNA methylation
levels and serum androgen levels in PA monkeys.
Probe numbers Gene Symbol P value R value
Infant
26884 GLO1 0.041 0.91
3190* DDB1 0.030 20.97
Adult
11987 SUV39H2 0.018 0.97
26822 OACT2 0.031 0.88
4479 SEPT9 0.032 20.88
15743 KCNQ5 0.041 0.84
10272 RAB6A 0.042 0.83
21784 PRKD1 0.043 20.83
2171 OBFC2B 0.049 0.81
*All probes were associated with testosterone, except that DDB1 was associated
with androstenedione.
doi:10.1371/journal.pone.0027286.t004
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ed). This assay simultaneously measures methylation levels at
27,578 CpG sites in or within 1.5 kb of 14,475 genes.
Quality control
Background-corrected b values and built-in controls were used
to evaluate the quality of individual arrays. Sample quality was
evaluated via bisulfite conversion efficiency and outliers on
histograms of b values. Samples were filtered using the Beadstudio
P-values of detection of signal above background.
After the first quality control step, samples were subjected to
principal component analysis (PCA) to identify outliers, if any.
Infant and adult samples were analyzed separately since they were
performed on different dates. After generating eigenvalues, samples
were analyzed against the top principal components to determine
whether experimental factors such as batch/plate, DNA input
(amount and quality) were associated with principal components.
Linear regression was performed for continuous variables such as
DNA amount and quality (ODs of 260/280), and logistic regression
was performed for nominal variables such as batch/plate.
Unsupervised hierarchical clustering
Cluster analysis was performed to divide samples into groups on
the basis of similarities among their DNA methylation profile using
TIGR MeV (http://www.tm4.org/mev/) [59]. Infant and adult
data sets were clustered separately.
Bayesian Classification with Singular Value
Decomposition (BCSVD)
Two experiments were evaluated: PA infants versus control
infants, and PA adults versus control adults. The BCSVD method
was utilized to identify significantly differentially methylated
probes in the genome-wide methylation data. BCSVD is a
practical method to identify genetic determinants in large scale
association studies when the sample size is much smaller than the
number of markers [60]. In contrast to most current statistical
methods, which analyze one genetic variant at a time, this method
tests all probes simultaneously in a single test, thus avoiding the
multiple testing problem. The BCSVD method achieves dimen-
sion reduction by applying singular value decomposition (SVD) to
the design matrix in the model. Model fitting was achieved via
Markov chain Monte Carlo (MCMC) with Gibbs sampler.
Significant probes were selected based on the empirical P values
(,0.05) that were calculated using permutation.
Criteria for experimentally valid probes
Each probe consists of 50 nucleotides matching a CpG site at
the end. To handle sequence dissimilarities between human
probes and monkey DNA template, we formulated stringent
criteria to filter all probes with significant BCSVD P values by
performing alignments of the human probes to the monkey
genome. These criteria were: 1) the 39 end of the probe with the
CG end had to match between the human probe and monkey
DNA, to enable single base extension and thus detection; 2) the
number of mismatched nucleotides of alignments was less than or
equal to 3 of the 50-nucleotide probe, such that identity was
greater than or equal to 94%; and 3) if multiple matches were
found among alignments, only the genomic sequence containing
the top match with 100% identity was selected to be valid. Those
probes that met these criteria were retained for further
exploration, and others were removed from the list. Re-analysis
revealed that removal of invalid probes did not affect overall
results generated with BCSVD.
Next we mapped all statistically significant probes to the rhesus
genome using Blat (http://genome.ucsc.edu/cgi-bin/hgBlat), to
confirm 1) gene annotations of those probes from the human
genome-based array are the same as their gene annotations in the
rhesus genome; and 2) probes are located within 1.5 kb upstream
of the transcription start site or overlapping the gene body in the
rhesus genome, similar to how they were designed for humans in
the Infinium arrays. This ensured the human gene annotations for
CpG sites were accurate for the monkey genome.
Statistical validation and power analysis
Within each experiment (infant and adult, respectively), we
evaluated the validity of the fitted model with all probes selected as
significant (P,0.05, and meeting criteria for experimentally valid)
to distinguish PA monkeys from controls, utilizing leave-one-out
cross-validation (LOOCV) analysis. LOOCV leaves one sample
out at a time, fits the model on the remaining samples, and then
uses the model to predict the case/control status of the held out
subject. If the fitted model is valid, we can expect a high accuracy
rate for its predictions.
The power of each model (infant and adult) was estimated using
the generalized likelihood ratio (GLR) under the null hypothesis
H0 : intercept only model versus the alternative H1 : the model
with all selected probes. Power =1 – Pr(reject H0) =1 – Pr(x
2(1)$
–2lnl), where l is the GLR under H0. For large sample size, -2lnl
follows a chi-square distribution with one degree of freedom.
Pathway analysis
The two differentially-methylated gene sets from both infant
and adult data were analyzed through the use of Ingenuity
Pathways Analysis (IPA) (Ingenuity Systems, Redwood City, CA,
www.ingenuity.com). Canonical pathways in the Core analysis
identified the pathways from the Ingenuity Knowledge Base
library of canonical pathways that were most significant to the data
set. The significance of the association between the data set and
the canonical pathway was measured in 2 ways: 1) the right tailed
Fisher’s exact test was used to calculate a P value, and significance
was taken as P value ,0.05; 2) a ratio of the number of molecules
from the data set that map to the pathway divided by the total
number of molecules comprising the canonical pathway.
Furthermore, we used the PANTHER (Protein ANalysis
THrough Evolutionary Relationships) program. PANTHER can
compare input gene lists to any reference gene list, and identify
significant pathways that are either over-represented or under-
represented by the input list [32]. We used the entire gene list of
the HumanMethylation27 chip as a reference set, instead of the
human RefSeq. This analysis enabled us to determine whether our
results were biased by the array structure.
Network Analysis
To find networks of highly connected focus genes (input genes),
network analysis in the Core analysis was performed in IPA,
representing the molecular relationships between gene products.
Core networks contained both direct and indirect interactions.
Each uploaded gene symbol was mapped to its corresponding gene
object (focus gene) in the Ingenuity Pathways Knowledge Base,
and focus genes were selected as ‘‘seed’’ elements to generate
networks with the highest connectivity to other focus genes. Non-
focus genes that were not among our differentially methylated
gene lists were also added if they contained links to the network.
Networks were scored for the likelihood of finding the focus
molecules in that given network. The ranking score for each
network was computed based on the right tailed Fisher’s Exact
Epigenetics in Prenatally Androgenized Monkeys
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27286Test as the negative log of the probability that the number of focus
genes in the network was due to random chance.
Association analysis between phenotypes and
methylation profiles
Association testing was performed using the GoldenHelix
(Bozeman, Montana) program. Numeric variables such as
androgens were analyzed for correlation with methylation levels
using linear regression, corrected for multiple testing including
Bonferroni correction and false discovery rate.
Supporting Information
Figure S1 Diagrams of the significant canonical pathways
detected in PA infant (top) and PA adult (bottom) VAT versus
age-specific controls. Shaded genes (red) are input molecules with
differential methylation. Panel A displays the most significant
pathway from infant data:, the antiproliferative role of TOB in T-
cell signaling, which includes PABP1, SMAD4, and P27KIP1 that
are differentially methylated in infants. Panel B displays the most
significant pathway from adult data, TGF-b signaling, which
includes TGFB3, TGFBR1, KRAS, BMP2, TFE3, RUNX3 and
HOXC8 from the list of genes differentially methylated in adults.
Arrow-up (red) indicates hypermethylation; arrow-down (blue)
indicates hypomethylation relative to controls (also see Figure S3
for detailed explanation of shapes and relationships). Note: two
arrows of BMP2 indicate that the two probes of this gene were
significantly differentially methylated in opposite directions.
(TIF)
Figure S2 Significant networks connecting genes that were
significantly differentially methylated in PA VAT samples
compared to controls. Panel A displays the most significant
network from infant data, centered around Akt, hCG, ERK1/2,
LH, FSH, Creb and P38MAPK. Panel B displays the most
significant network from adult data, centered around Akt, ERK1/
2, NFkB, TGFBR1, ERBB2, hCG, CCND1, Creb and AR.
Molecules are represented as nodes, and the biological relationship
between two nodes is represented as an edge (line). Shaded factors
(red) are input molecules whose genes generated a significant
BSCVD P value. Darker shading of filled molecules represents a
lower and thus more significant BSCVD P value. Factors in
unfilled nodes were not among our differentially methylated list
but contained links to the network. Arrow-up (red) indicates
hypermethylation; arrow-down (blue) indicates hypomethylation
relative to controls (also see Figure S3 for detailed explanation of
shapes and relationships).
(TIF)
Figure S3 Keys to symbols in networks and pathways.
(TIF)
Table S1 Summary of regression analysis to determine whether
experimental factors were associated with any principal compo-
nents in infant data (top table) and adult data (bottom table). P
values are displayed in the table.
(DOC)
Table S2 163 significantly differentially methylated genes
deemed valid when comparing infant PA and control monkeys.
Median and interquartile range (IQR) are presented for control
and PA monkeys at each probe. Genes were sorted by BSCVD P
values.
(DOC)
Table S3 325 significantly differentially methylated genes
deemed valid when comparing adult PA and control monkeys.
Median and interquartile range (IQR) are presented for control
and PA monkeys at each probe. Genes were sorted by BSCVD P
values.
(DOC)
Table S4 Full names of genes in text.
(DOC)
Table S5 PANTHER pathway analysis generated with the
Human Methylation27 genes as the reference list.
(DOC)
Table S6 The highest scoring molecule networks in PA infant
and adult female monkeys. * = involved in TGF-b signaling;
** = involved in reproduction; *** = involved in adipogenesis.
(DOC)
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